Abbvie reported $11.29B in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Abbvie ABBV:US $ 11288M 2467M
ALKERMES ALKS:US 310.68M 5.55M
Amgen AMGN:US $ 4.42B 680M
AstraZeneca AZN:LN 10.23B 280M
Astrazeneca AZN:US 10.23B 280M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Chemocentryx CCXI:US $ 43.34M 355K
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Eisai 4523:JP Y 176828M 34876M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Horizon Pharma HZNP:US $ 787.85M 96.93M
Infinity Pharmaceuticals INFI:US $ 12.7M 355K
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Johnson & Johnson JNJ:US $ 18.18B 616M
Medtronic MDT:US $ 6418M 314M
Merk MRK:US $ 9666M 666M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Revance Therapeutics RVNC:US $ 86.21M 1.27M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Zoetis ZTS:US $ 1.38B 123M